
Browsing restrictions can be lifted for a fee.
-
Sharps technology, inc.
0.05%
Avg of Sector
-0.31%
S&P500

Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2026Q1 | ||||
| 2026Q2 | ||||
| 2026Q3 | ||||
| 2026Q4 | ||||
| 2027Q1 |
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for Sharps technology, inc. (STSSW) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating STSSW's short-term business performance and financial health. For the latest updates on STSSW's earnings releases, visit this page regularly.
According to the latest financial report, Sharps technology, inc. (STSSW) reported an Operating Profit of -110.65M with an Operating Margin of -4,833.73% this period, representing a decline of 5,390.56% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, Sharps technology, inc. (STSSW) announced revenue of 2.29M, with a Year-Over-Year growth rate of 0%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, Sharps technology, inc. (STSSW) held Total Cash and Cash Equivalents of 11.02M, accounting for 0.02 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, Sharps technology, inc. (STSSW) did not achieve the “three margins increasing” benchmark, with a gross margin of -463.37%%, operating margin of -1,349.84%%, and net margin of 1,598.09%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess STSSW's profit trajectory and future growth potential.
According to the past four quarterly reports, Sharps technology, inc. (STSSW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -4.33. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
Sharps technology, inc. (STSSW)'s Free Cash Flow (FCF) for the period is -3.77M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 127.96% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
The latest valuation data shows Sharps technology, inc. (STSSW) has a Price-To-Earnings (PE) ratio of 0.38 and a Price/Earnings-To-Growth (PEG) ratio of -0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.